Drug Use in the Elderly

Preview:

DESCRIPTION

- PowerPoint PPT Presentation

Citation preview

UMMS CRIT Module II: Drug Therapy in the Elderly

Jerry H. Gurwitz, MDChief, Division of Geriatric MedicineUniversity of Massachusetts Medical SchoolUMass Memorial Medical Center

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

It is much easier to write upon a disease than upon a remedy.

The former is in the hands of nature and a faithful observer with

an eye of tolerable judgement cannot fail to delineate a likeness.

The latter will ever be subject to the whim, the inaccuracies and

the blunder of mankind.

William Withering (1741-1799)

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

A desire to take medicine is, perhaps, the great feature which

distinguishes man from other animals.

Sir William Osler, 1891

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

“I know of no way to end an office visit as satisfactorily and as efficiently as by writing a prescription. The patient knows that the visit is over and is expected to leave. He has something in his hand that he thinks will help him and obtaining it required an office visit.”

Marcus Reidenberg, MDEditor Emeritus, CP&T

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

Drug Use in the Elderly

• 57% of all elderly use > 5 drugs per week

• 19% of elderly use > 10 drugs per week

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

• Overuse

• Inappropriate prescribing

• Underuse

Suboptimal Medication Use

Hanlon JT et al. JAGS. 2001;49: 200-9. Fisk D et al. Arch Intern Med. 2003;163: 2716-2724.

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

Polypharmacy is not necessarily bad!

Polypharmacy

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

• Any transition - hospitalizations, discharges, ER visits, subacute

care stays

• New meds, different doses…

• Changes from generic to brand- nomenclature, color and/or shape

Drug Regimen Changes ~They are very common!

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

• The more providers and visits, the more medications are prescribed

• 2/3 of all physician visits end with a prescription

• Expectations of the patient to receive a prescription

• Lack of communication between prescribers

• Self-treatment: unbeknownst to the physician

Why so many changes?

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

• Increased risk of adverse drug events and near-misses

• Noncompliance or nonadherence leading to poor outcomes

• Increased costs

Impact on the Patient

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

• Multiple co-existing illnesses

• Polypharmacy: redundant effects and drug-drug interactions

• Adverse drug effects nonspecific

• Pharmacologic changes with aging

• Medical error

Factors Influencing Drug Effects and Risk of Adverse Effects in the Elderly

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

• Absorption• Distribution• Metabolism• Excretion

Pharmacokinetics: Changes with Aging

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

Body Composition Changes in Adult Men with Aging

Age Group Body Weight (kg) Body Fat (kg) Muscle Mass

(kg)

20-29 80 15 24

30-49 81 19 20

60-69 79 23 17

70-79 80 25 13

Data adapted from Cohn et al, 1980

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

• Phase I reactions- primarily oxidative reactions– Decline in efficiency with aging

• Phase II reactions- conjugation reactions– No decline in efficiency with aging

Hepatic Metabolism of DrugsChanges with Aging

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

Renal Function: Changes with Aging

AgeCR

EAT

ININ

E C

LE

AR

AN

CE

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

t1/2 ~ Vd/Clearance

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

Pharmacodynamics: Changes with Aging

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

Clinical Pearl

Any new symptom in an elderly patient should be considered a drug side effect until proven otherwise.

Jerry Avorn, MD

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

The Prescribing Cascade

Drug 1

ADE

Drug 2

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

The Prescribing Cascade

Metoclopramide

Extrapyramidal Effects

Levodopa Rx

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

Case-Control Study Design

Metoclopramide:Yes or No?

Metoclopramide:Yes or No?

BEGIN

L-dopaRx

Controls

CLASSIFY/COMPARE

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

Results

Metoclopramide users were over three times more

likely to begin use of L-dopa therapy compared with

non-users (OR=3.09; 95% CI 2.25 to 4.26).

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

Likelihood of L-dopa Treatment by Metoclopramide Dose

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

Conclusion

Metoclopramide confers an increased risk for the

initiation of treatment generally reserved for the

managment of idiopathic Parkinson’s disease.

Avorn et al, JAMA, 1995

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

• Medication reconciliation – at time of transitions

• Anticipate errors – prescribing & monitoring

• Watch out for prescribing cascades

• Simplify the medication regimen

• Identify obstacles (costs, cognitive impairment)

• Enlist family/nursing/PCP support & involvement

• Make sure there is good follow-up

Improving the Quality of Prescribing to Older Adults

UMMS CRIT 2012 Module II: Drug Therapy in the Elderly

Advancing Geriatrics Education (AGE) A UMMS initiative funded by the Donald W. Reynolds Foundation

Lessons from the Case

Recommended